1,107
Views
1
CrossRef citations to date
0
Altmetric
Health Services

The involvement of palliative care with neurology – a comparison of UK, Switzerland and Italy

ORCID Icon, , ORCID Icon, , ORCID Icon, , , , , ORCID Icon, & ORCID Icon show all
Pages 256-262 | Received 22 Jun 2022, Accepted 12 Oct 2022, Published online: 26 Oct 2022

References

  • Clark D. Cicely Saunders, founder of the hospice movement. Selected Letters 1959–1999. Oxford: Oxford University Press; 2002:322.
  • Neudert C, Oliver D, Wasner M, Borasio GD. The course of the terminal phase in patients with amyotrophic lateral sclerosis. J Neurol. 2001;248:612–6.
  • O'Brien T, Kelly M, Saunders C. Motor neurone disease: a hospice perspective. BMJ. 1992;304:471–3.
  • Oliver D, Borasio GD, Veronese S, Voltz R, Lorenzl S, Hepgul N. Current collaboration between palliative care and neurology: a survey of clinicians in Europe. BMJ Support Palliat Care. 2020:1–6. doi:10.1136/bmjspcare-2020-002322.
  • Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, EFNS Task Force on Diagnosis and Management of Amyotrophic Lateral Sclerosis, et al. and the members of the EFNS Task Force. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis: revised report of an EFNS task force. Eur J Neurol. 2012;19:360–75.
  • National Institute for Health and Care Excellence. NICE guidance on motor neurone disease. 2016. NICE. Available at: www.nice.org.uk/NG42.
  • Veronese S, Gallo G, Valle A, Cugno C, Chio A, Calvo A, et al. Specialist palliative care improves the quality of life in advanced neurodegenerative disorders: Ne-PAL, a pilot randomized controlled study. BMJ Support Palliat Care. 2017;7:164–72.
  • Buzgova R, Kozakova R, Bar M. The effect of neuropalliative care on quality of life and satisfaction with quality of care in patients with progressive neurological disease and their family caregivers: an interventional control study. BMC Palliat Care. 2020;19:143.
  • Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, et al. Comparison of integrated outpatient palliative care with standard care in patients with Parkinson disease and related disorders: a randomized clinical trial. JAMA Neurol. 2020;77:551–60.
  • Oliver D, Webb S. The involvement of specialist palliative care in the care of people with motor neurone disease. Palliat Med. 2000;14:427–8.
  • Aridegbe T, Kandler R, Walters SJ, Walsh T, Shaw PJ, McDermott CJ, et al. The natural history of motor neuron disease: assessing the impact of specialist care. Amyotroph Lateral Scler Frontotemporal Degener. 2013;14:13–9.
  • Rooney J, Byrne S, Heverin M, Tobin K, Dick A, Donaghy C, et al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J Neurol Neurosurg Psychiatry. 2015; 86:496–501.
  • Scott A, McPhee M. Multidisciplinary care: speech and language therapy. In: Oliver D, Borasio GD, Johnston W, eds. Palliative care in ALS – from diagnosis to bereavement. 3rd ed. Oxford. Oxford University Press; 2014.
  • Fried-Oken M, Mooney A, Peters B. Supporting communication for patients with neurodegenerative disease. NeuroRehabilitation 2015;37:69–87.
  • Bede P, Oliver D, Stodart J, van den Berg L, Simmons Z, O’Brannagain D, et al. Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives. J Neurol Neurosurg Psychiatry. 2011;82:413–8.
  • Chiò A, Bottacchi E, Buffa C, Mutani R, Mora G, PARALS Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital services. J Neurol Neurosurg Psychiatry. 2006;77:948–50.
  • Collins A, McLachlan SA, Philip J. Initial perceptions of palliative care: An exploratory qualitative study of patients with advanced cancer and their family caregivers. Palliat Med. 2017;31:825–32.
  • Collins A, McLachlan SA, Philip J. Community knowledge and attitudes to palliative care: a descriptive study. Palliat Med. 2020; 34:245–52.
  • Hudson P, Collins A, Boughey M, Philip J. Reframing palliative care to improve the quality of life of people diagnosed with a serious illness. Med J Aust. 2021; 215:443–446.
  • Gleeson A, Johnson F. Assisted ventilation in motor neurone disease during inpatient palliative care: barriers and utilization. BMJ Support Palliat Care. 2020;10:358–62.
  • Turner MR, Faull C, McDermott CJ, Nickol AH, Palmer J, Talbot K. Tracheostomy in motor neurone disease. Pract Neurol. 2019;19:467–75.
  • Chio A, Moglia C, Canosa A, Manera U, Vasta R, Grassano M, et al. Respiratory support in a population-based ALS cohort: demographic, timing and survival determinants. J Neurol Neurosurg Psychiatry. 2022;93:1024–6.
  • Spittel S, Maier A, Kettemann D, Walter B, Koch B, Krause K, et al. Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: utilization and survival rates in a cohort study over 12 years in Germany. Eur J Neurol. 2021;28:1160–71.
  • Veronese S, Valle A, Chio A, Calvo A, Oliver D. the last months of life of people with amyotrophic lateral sclerosis in mechanical invasive ventilation: a qualitative study. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15:499–504.
  • Chio A, Calvo A, Ghiglione P, Mazzini L, Mutani R, Mora G, PARALS Tracheostomy in amyotrophic lateral sclerosis: a 10-year population-based study in Italy. J Neurol Neurosurg Psychiatry. 2010;81:1141–3.
  • Faull C, Oliver D. Withdrawal of ventilation at the request of a patient with motor neurone disease: guidance for professionals. BMJ Support Palliat Care. 2016;6:144–6.